Deferoxamine in Myeloablative Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndromes or Acute Leukemia and Iron Overload

This study has been terminated.

( Closed due to slow patient accrual )

Study NCT00658411 Information provided by Dana-Farber Cancer Institute

First Received: March 31, 2008 Last Updated: January 19, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2011
Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)